Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jeffry Yaplee"'
Autor:
Eunnara Cho, Carol D. Swartz, Andrew Williams, Miriam Rivas, Leslie Recio, Kristine L. Witt, Elizabeth K. Schmidt, Jeffry Yaplee, Thomas H. Smith, Phu Van, Fang Yin Lo, Charles C. Valentine, Jesse J. Salk, Francesco Marchetti, Stephanie L. Smith-Roe, Carole L. Yauk
Error-corrected Duplex Sequencing (DuplexSeq) enables direct quantification of low-frequency mutations and offers tremendous potential for chemical mutagenicity assessment. We investigated the utility of DuplexSeq to quantify induced mutation frequen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0297e7108e98c4ad7df2f12bf5adc5ad
https://doi.org/10.1101/2023.02.22.529418
https://doi.org/10.1101/2023.02.22.529418
Autor:
Eunnara Cho, Carol D. Swartz, Andrew Williams, Miriam Rivas, Leslie Recio, Kristine L. Witt, Elizabeth K. Schmidt, Jeffry Yaplee, Thomas H. Smith, Phu Van, Fang Yin Lo, Charles C. Valentine, Jesse J. Salk, Francesco Marchetti, Stephanie L. Smith-Roe, Carole L. Yauk
Publikováno v:
Mutation Research/Genetic Toxicology and Environmental Mutagenesis. :503649
Autor:
Elizabeth K. Schmidt, Roberta A. Mittelstaedt, Timothy W. Robison, Xuefei Cao, Ying Chen, Wei Sun, Rebecca Wynne, Yiying Wang, Levan Muskhelishvili, Charles C. Valentine, Thomas H. Smith, Lindsey N. Williams, Zachary K Norgaard, Robert H. Heflich, Kelly Davis, Jesse J. Salk, Jeffry Yaplee
Publikováno v:
Environmental and Molecular Mutagenesis
The organotypic human air‐liquid‐interface (ALI) airway tissue model has been used as an in vitro cell culture system for evaluating the toxicity of inhaled substances. ALI airway cultures are highly differentiated, which has made it challenging
Autor:
Megan Othus, Jacob Higgins, Brent L. Wood, Fang Yin Lo, Jeffry Yaplee, Thomas H. Smith, Laura W. Dillon, Elizabeth K. Schmidt, Christopher S. Hourigan, Jesse J. Salk, Charles C. Valentine, Jerald P. Radich
Publikováno v:
Blood. 138:3475-3475
Background: The presence of measurable residual disease (MRD) is strongly associated with treatment outcomes in acute myeloid leukemia (AML). However, > 20% of MRD negative cases (as assessed by flow cytometry) subsequently relapse. We sought to dete